Barbara Bispham, Senda Biosciences' newly hired general counsel, said the business is at "an exciting inflection point."
October 20, 2022 at 08:13 AM
2 minute read
Biopharmaceutical company Senda Biosciences announced Wednesday that veteran biotech attorney Barbara Bispham has joined its leadership roster as general counsel.
Bispham joins Senda from BridgeBio Pharma, where she was head of legal. At Senda, she replaces Lynette Herscha, who left in July to become chief operating officer at Immunitas Therapeutics.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
(Credit: ipopba/Adobe Stock)
Barbara Bispham, general counsel of Senda Biosciences. (Courtesy photo)
